Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Detomidine
2. Detomidine Monohydrochloride
1. 90038-01-0
2. Detomidine Hcl
3. Domosedan
4. Mpv-253 Aii
5. Detomidine Hydrochloride [usan]
6. Detomidine (hydrochloride)
7. 5-(2,3-dimethylbenzyl)-1h-imidazole Hydrochloride
8. 5-[(2,3-dimethylphenyl)methyl]-1h-imidazole Hydrochloride
9. 4-(2,3-dimethylbenzyl)imidazole Monohydrochloride
10. 95k4lkb6qe
11. 1h-imidazole, 4-[(2,3-dimethylphenyl)methyl]-, Monohydrochloride
12. 4-(2,3-dimethylbenzyl)-1h-imidazole Hydrochloride
13. Mfcd17292784
14. 1h-imidazole, 4-((2,3-dimethylphenyl)methyl)-, Monohydrochloride
15. 5-(2,3-dimethylbenzyl)imidazole Hydrochloride
16. Dsstox_cid_28587
17. Dsstox_rid_82858
18. 4-(2,3-dimethylbenzyl)-1h-imidazole Hcl
19. Dsstox_gsid_48661
20. Detomidine Hydrochloride (usan)
21. 5-[(2,3-dimethylphenyl)methyl]-1h-imidazole;hydrochloride
22. Cas-90038-01-0
23. Ncgc00182057-02
24. Unii-95k4lkb6qe
25. 4-[(2,3-dimethylphenyl)methyl]-1h-imidazole;hydrochloride
26. 4-(2',3'-dimethylbenzyl)imidazole Hydrochloride
27. 4-((2,3-dimethylphenyl)methyl)-1h-imidazole Hydrochloride
28. Schembl203174
29. Chembl2106210
30. Dtxsid7048661
31. Hy-b0163a
32. Amy6987
33. Bcp06805
34. Tox21_113020
35. Ac-309
36. Detomidine Hydrochloride [mi]
37. S2092
38. Akos024464193
39. Akos025149295
40. Tox21_113020_1
41. As-2744
42. Ccg-266742
43. Cs-1996
44. Sb39723
45. Detomidine Hydrochloride [mart.]
46. Ncgc00182057-03
47. Sy046831
48. D4331
49. Detomidine Hydrochloride [green Book]
50. Ft-0666296
51. Sw219456-1
52. D03702
53. 4-[(2,3-dimethylbenzyl)]imidazole Hydrochloride
54. 038d010
55. 5-[(2,3-dimethylphenyl)methyl]-1h-imidazole Hcl
56. A854060
57. Detomidine Hydrochloride For Veterinary Use
58. 4-(2'',3''-dimethylbenzyl)imidazole Hydrochloride
59. J-516575
60. Q27271799
61. 4-(2,3-dimethylbenzyl)-1h-imidazole Hydrochloride (1:1)
62. 4-[(2,3-dimethylphenyl)methyl]-3h-imidazole Hydrochloride
63. Detomidine Hydrochloride For Veterinary Use [ep Monograph]
64. Detomidine Hydrochloride; Mpv-253 Hcl; Mpv 253 Hcl; Mpv253 Hcl
65. 4-[(2,3-dimethylphenyl)methyl]-1h-imidazole Monohydrochloride;detomidine Hcl
Molecular Weight | 222.71 g/mol |
---|---|
Molecular Formula | C12H15ClN2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 2 |
Exact Mass | 222.0923762 g/mol |
Monoisotopic Mass | 222.0923762 g/mol |
Topological Polar Surface Area | 28.7 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 181 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Adrenergic alpha-2 Receptor Agonists
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Detomidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Detomidine, including repackagers and relabelers. The FDA regulates Detomidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Detomidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Detomidine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Detomidine supplier is an individual or a company that provides Detomidine active pharmaceutical ingredient (API) or Detomidine finished formulations upon request. The Detomidine suppliers may include Detomidine API manufacturers, exporters, distributors and traders.
click here to find a list of Detomidine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Detomidine CEP of the European Pharmacopoeia monograph is often referred to as a Detomidine Certificate of Suitability (COS). The purpose of a Detomidine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Detomidine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Detomidine to their clients by showing that a Detomidine CEP has been issued for it. The manufacturer submits a Detomidine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Detomidine CEP holder for the record. Additionally, the data presented in the Detomidine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Detomidine DMF.
A Detomidine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Detomidine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Detomidine suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Detomidine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Detomidine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Detomidine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Detomidine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Detomidine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Detomidine suppliers with NDC on PharmaCompass.
Detomidine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Detomidine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Detomidine GMP manufacturer or Detomidine GMP API supplier for your needs.
A Detomidine CoA (Certificate of Analysis) is a formal document that attests to Detomidine's compliance with Detomidine specifications and serves as a tool for batch-level quality control.
Detomidine CoA mostly includes findings from lab analyses of a specific batch. For each Detomidine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Detomidine may be tested according to a variety of international standards, such as European Pharmacopoeia (Detomidine EP), Detomidine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Detomidine USP).
LOOKING FOR A SUPPLIER?